UnitedHealth Group (UNH) PT Raised to $161 at Oppenheimer

Argus Upgrades UnitedHealth Group (UNH) to Buy

Argus upgraded UnitedHealth Group (NYSE: UNH) from Hold to Buy with a price target of $170.00.

The firm thinks the company's decision to exit most of the ACA public exchange markets in 2017 will limit its exposure to unprofitable business and lead to... More

UnitedHealth Group (UNH) PT Raised to $155 at Credit Suisse Post Q2

Credit Suisse analyst S. Fidel reiterated an Outperform rating and lifted his price target on UnitedHealth Group (NYSE: UNH) to $155.00 (from $148.00) following Q2 results.

Fidel commented, "UNH's growth thesis continues to separate from the rest of the pack: While UNH's challenges in the public exchanges once again put a damper on an otherwise strong 2Q report, the company appears to be setting up increasingly well for 15%+ EPS growth in 2017. First, the planned exits... More

Leerink Partners Reiterates Outperform on UnitedHealth Group (UNH) Following 2Q Beat and Raise

Leerink Partners reiterated an Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $165.00 (from $155.00), following the company's 2Q earnings report. UNH reported a 7c EPS beat and $1.5B revenue beat with a conservative EPS guidance raise of 2.5c.

Analyst Ana Gupte commented, "Importantly, the Consolidated MLR miss of 40 bps was underpinned by a meaningfully conservative incremental estimated loss in the ObamaCare... More

UnitedHealth (UNH) PT Raised to $155 at FBR Capital

FBR Capital analyst Steven Halper reiterating an Outperform rating and lifted his price target on UnitedHealth Group (NYSE: UNH) to $155.00 (from $145.00) following Q2 results, which were "solid across the board."

Halper commented, "Revenue was in line with our estimate at $45.5 billion, and... More

UnitedHealth (UNH) PT Raised to $160 at Mizuho Post Q2

Mizuho Securities analyst Sheryl Skolnick reiterating an Outperform rating and boosted her price target on UnitedHealth Group (NYSE: UNH) to $160.00 (from $156.00) following Q2 results.

"We see further upside to our new 2016/17 estimates and raise our PT to $160 from $156 as we see UNH's long-term earnings power... More

UnitedHealth Group (UNH) Tops Q2 EPS by 7c

UnitedHealth Group (NYSE: UNH) reported Q2 EPS of $1.96, $0.07 better than the analyst estimate of $1.89. Revenue for the quarter came in at $46.5 billion versus the consensus estimate of $45.05 billion.

GUIDANCE:

UnitedHealth Group sees FY2016 EPS of $7.80-$7.95, versus the consensus of... More